The DOI matches its Crossref record; 297 of the 297 references it cites were found in a registry or an index.
Cell Adhesion Molecules and Their Roles and Regulation in the Immune and Tumor Microenvironment
Open accessAbstract
The immune system and cancer have a complex relationship with the immune system playing a dual role in tumor development. The effector cells of the immune system can recognize and kill malignant cells while immune system-mediated inflammation can also promote tumor growth and regulatory cells suppress the anti-tumor responses. In the center of all anti-tumor responses is the ability of the immune cells to migrate to the tumor site and to interact with each other and with the malignant cells. Cell adhesion molecules including receptors of the immunoglobulin superfamily and integrins are of crucial importance in mediating these processes. Particularly integrins play a vital role in regulating all aspects of immune cell function including immune cell trafficking into tissues, effector cell activation and proliferation and the formation of the immunological synapse between immune cells or between immune cell and the target cell both during homeostasis and during inflammation and cancer. In this review we discuss the molecular mechanisms regulating integrin function and the role of integrins and other cell adhesion molecules in immune responses and in the tumor microenvironment. We also describe how malignant cells can utilize cell adhesion molecules to promote tumor growth and metastases and how these molecules could be targeted in cancer immunotherapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
A homing system targets therapeutic T cells to brain cancer
Samaha, H., Pignata, A., Fousek, K., Ren, J. P., Lam, F. W., Stossi, F., Dubrulle, J., Salsman, V. S., Krishnan, S., Hong, S., et al. (2018) · Nature · doi:10.1038/s41586-018-0499-y · Cited by 43
RetractedHallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Immunity, Inflammation, and Cancer
Grivennikov, S. I., Greten, F. R., & Karin, M. (2010) · Cell · doi:10.1016/j.cell.2010.01.025 · Cited by 10,755
Mizgerd, J. P., Kubo, H., Kutkoski, G. J., Bhagwan, S. D., Scharffetter-Kochanek, K., Beaudet, A. L., & Doerschuk, C. M. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.8.1357 · Cited by 7,306
Myeloid-derived-suppressor cells as regulators of the immune system
Gabrilovich, D. I., & Nagaraj, S. (2009) · Nature Reviews Immunology · doi:10.1038/nri2506 · Cited by 6,753
Adhesion receptors of the immune system
Springer, T. A. (1990) · Nature · doi:10.1038/346425a0 · Cited by 6,477
Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion
Schreiber, R. D., Old, L. J., & Smyth, M. J. (2011) · Science · doi:10.1126/science.1203486 · Cited by 6,474
Regulatory T Cells and Immune Tolerance
Sakaguchi, S., Yamaguchi, T., Nomura, T., & Ono, M. (2008) · Cell · doi:10.1016/j.cell.2008.05.009 · Cited by 5,325
Curiel, T. J., Coukos, G., Zou, L., Alvarez, X., Cheng, P., Mottram, P., Evdemon-Hogan, M., Conejo-Garcia, J. R., Zhang, L., Burow, M., et al. (2004) · Nature Medicine · doi:10.1038/nm1093 · Cited by 5,151
The immune contexture in human tumours: impact on clinical outcome
Fridman, W. H., Pagès, F., Sautès-Fridman, C., & Galon, J. (2012) · Nature reviews. Cancer · doi:10.1038/nrc3245 · Cited by 4,981
Getting to the site of inflammation: the leukocyte adhesion cascade updated
Ley, K., Laudanna, C., Cybulsky, M. I., & Nourshargh, S. (2007) · Nature Reviews Immunology · doi:10.1038/nri2156 · Cited by 4,354
Integrins in cancer: biological implications and therapeutic opportunities
Desgrosellier, J. S., & Cheresh, D. A. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2748 · Cited by 3,736
Chimeric antigen receptor–modified T cells in chronic lymphoid leukemia
Porter, D. L., Levine, B. L., Kalos, M., Bagg, A., & June, C. H. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1103849 · Cited by 3,565
A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human Melanoma
van der Bruggen, P., Traversari, C., Chomez, P., Lurquin, C., De Plaen, E., Van den Eynde, B., Knuth, A., & Boon, T. (1991) · Science · doi:10.1126/science.1840703 · Cited by 3,545
The Immunological Synapse: A Molecular Machine Controlling T Cell Activation
Grakoui, A., Bromley, S. K., Sumen, C., Davis, M. M., Shaw, A. S., Allen, P. M., & Dustin, M. L. (1999) · Science · doi:10.1126/science.285.5425.221 · Cited by 3,102
Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards
Bronte, V., Brandau, S., Chen, S.-H., Colombo, M. P., Frey, A. B., Greten, T. F., Mandruzzato, S., Murray, P. J., Ochoa, A., Ostrand-Rosenberg, S., et al. (2016) · Nature Communications · doi:10.1038/ncomms12150 · Cited by 2,751
Sato, E., Olson, S. H., Ahn, J., Bundy, B., Nishikawa, H., Qian, F., Jungbluth, A. A., Frosina, D., Gnjatic, S., Ambrosone, C., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509182102 · Cited by 2,372
Raje, N., & Anderson, K. C. (2000) · Current Treatment Options in Oncology · doi:10.1007/s11864-000-0017-x · Cited by 2,163
The Nature of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment
Kumar, V., Patel, S., Tcyganov, E., & Gabrilovich, D. I. (2016) · Trends in Immunology · doi:10.1016/j.it.2016.01.004 · Cited by 2,008
Regulatory T cells in cancer immunotherapy
Tanaka, A., & Sakaguchi, S. (2017) · Cell Research · doi:10.1038/cr.2016.151 · Cited by 1,860
Role of integrins in cell invasion and migration
Hood, J. D., & Cheresh, D. A. (2002) · Nature Reviews Cancer · doi:10.1038/nrc727 · Cited by 1,777
Robbins, P. F., Morgan, R. A., Feldman, S. A., Yang, J. C., Sherry, R. M., Dudley, M. E., Wunderlich, J. R., Nahvi, A. V., Helman, L. J., Mackall, C. L., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.32.2537 · Cited by 1,632
Nakamura, K., Kitani, A., & Strober, W. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.5.629 · Cited by 1,594
Mittal, D., Gubin, M. M., Schreiber, R. D., & Smyth, M. J. (2014) · Current Opinion in Immunology · doi:10.1016/j.coi.2014.01.004 · Cited by 1,471
Mucins in cancer: function, prognosis and therapy
Kufe, D. W. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2761 · Cited by 1,396
Kochenderfer, J. N., Wilson, W. H., Janik, J. E., Dudley, M. E., Stetler-Stevenson, M., Feldman, S. A., Maric, I., Raffeld, M., Nathan, D.-A. N., Lanier, B. J., et al. (2010) · Blood · doi:10.1182/blood-2010-04-281931 · Cited by 1,337
Almand, B., Clark, J. I., Nikitina, E., van Beynen, J., English, N. R., Knight, S. C., Carbone, D. P., & Gabrilovich, D. I. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.1.678 · Cited by 1,337
Metabolic Regulation of T Lymphocytes
MacIver, N. J., Michalek, R. D., & Rathmell, J. C. (2013) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032712-095956 · Cited by 1,244
Albert, M. L., Pearce, S. F. A., Francisco, L. M., Sauter, B., Roy, P., Silverstein, R. L., & Bhardwaj, N. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.7.1359 · Cited by 1,234
Diaz-Montero, C. M., Salem, M. L., Nishimura, M. I., Garrett-Mayer, E., Cole, D. J., & Montero, A. J. (2009) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-008-0523-4 · Cited by 1,215
Broz, M. L., Binnewies, M., Boldajipour, B., Nelson, A. E., Pollack, J. L., Erle, D. J., Barczak, A., Rosenblum, M. D., Daud, A., Barber, D. L., et al. (2014) · Cancer Cell · doi:10.1016/j.ccell.2014.09.007 · Cited by 1,207
Salmon, H., Idoyaga, J., Rahman, A., Leboeuf, M., Remark, R., Jordan, S., Casanova-Acebes, M., Khudoynazarova, M., Agudo, J., Tung, N., et al. (2016) · Immunity · doi:10.1016/j.immuni.2016.03.012 · Cited by 1,201
Kumar, S. K., Rajkumar, V., Kyle, R. A., van Duin, M., Sonneveld, P., Mateos, M.-V., Gay, F., & Anderson, K. C. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.46 · Cited by 1,177
Chemokine expression in melanoma metastases associated with CD8+ T-cell recruitment
Harlin, H., Meng, Y., Peterson, A. C., Zha, Y., Tretiakova, M., Slingluff, C., McKee, M., & Gajewski, T. F. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2281 · Cited by 1,121 · cited 3×
“Hot tumors are characterized by transcripts encoding for various T Frontiers in Immunology | www.frontiersin.org 5 May 2019 | Volume 10 | Article 1078 cell-lineage markers, innate immune cell molecules, chemokines that regulate effector T cell recruitment and also for molecules mediating immune suppression such as PD-…”
BackgroundSuzuki, E., Kapoor, V., Jassar, A. S., Kaiser, L. R., & Albelda, S. M. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0883 · Cited by 1,054
Stupp, R., Hegi, M. E., Gorlia, T., Erridge, S. C., Perry, J., Hong, Y.-K., Aldape, K. D., Lhermitte, B., Pietsch, T., Grujicic, D., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70379-1 · Cited by 1,052
Structure and function of the leukocyte adhesion molecules CD11/CD18
Arnaout, M. (1990) · Blood · doi:10.1182/blood.v75.5.1037.1037 · Cited by 1,035
Jongbloed, S. L., Kassianos, A. J., McDonald, K. J., Clark, G. J., Ju, X., Angel, C. E., Chen, C.-J. J., Dunbar, P. R., Wadley, R. B., Jeet, V., et al. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20092140 · Cited by 1,027
Roberts, E. W., Broz, M. L., Binnewies, M., Headley, M. B., Nelson, A. E., Wolf, D. M., Kaisho, T., Bogunovic, D., Bhardwaj, N., & Krummel, M. F. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.06.003 · Cited by 1,026
Parkhurst, M. R., Yang, J. C., Langan, R. C., Dudley, M. E., Nathan, D.-A. N., Feldman, S. A., Davis, J. L., Morgan, R. A., Merino, M. J., Sherry, R. M., et al. (2011) · Molecular Therapy · doi:10.1038/mt.2010.272 · Cited by 1,020
Human T Regulatory Cells Can Use the Perforin Pathway to Cause Autologous Target Cell Death
Grossman, W. J., Verbsky, J. W., Barchet, W., Colonna, M., Atkinson, J. P., & Ley, T. J. (2004) · Immunity · doi:10.1016/j.immuni.2004.09.002 · Cited by 1,020
Shang, B., Liu, Y., Jiang, S.-J., & Liu, Y. (2015) · Scientific Reports · doi:10.1038/srep15179 · Cited by 985
Intercellular Adhesion Molecule-1 (ICAM-1) in the Pathogenesis of asthma
Wegner, C. D., Gundel, R. H., Reilly, P., Haynes, N., Letts, L. G., & Rothlein, R. (1990) · Science · doi:10.1126/science.1967851 · Cited by 898
Immune cell infiltration as an indicator of the immune microenvironment of pancreatic cancer
Ino, Y., Yamazaki-Itoh, R., Shimada, K., Iwasaki, M., Kosuge, T., Kanai, Y., & Hiraoka, N. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.32 · Cited by 849
MUC1: a multifaceted oncoprotein with a key role in cancer progression
Nath, S., & Mukherjee, P. (2014) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2014.02.007 · Cited by 837
Antiintegrin alpha v beta 3 blocks human breast cancer growth and angiogenesis in human skin.
Brooks, P. C., Strömblad, S., Klemke, R., Visscher, D., Sarkar, F. H., & Cheresh, D. A. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118227 · Cited by 828
Bachem, A., Güttler, S., Hartung, E., Ebstein, F., Schaefer, M., Tannert, A., Salama, A., Movassaghi, K., Opitz, C., Mages, H. W., et al. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20100348 · Cited by 822
Bidirectional Transmembrane Signaling by Cytoplasmic Domain Separation in Integrins
Kim, M., Carman, C. V., & Springer, T. A. (2003) · Science · doi:10.1126/science.1084174 · Cited by 786
Kohm, A. P., Carpentier, P. A., Anger, H. A., & Miller, S. D. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.9.4712 · Cited by 782
Serafini, P., Meckel, K., Kelso, M., Noonan, K., Califano, J., Koch, W., Dolcetti, L., Bronte, V., & Borrello, I. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20061104 · Cited by 766
Haniffa, M., Shin, A., Bigley, V., McGovern, N., Teo, P., See, P., Wasan, P. S., Wang, X.-N., Malinarich, F., Malleret, B., et al. (2012) · Immunity · doi:10.1016/j.immuni.2012.04.012 · Cited by 724
Phillipson, M., Heit, B., Colarusso, P., Liu, L., Ballantyne, C. M., & Kubes, P. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20060925 · Cited by 711
Kindlin-3 is essential for integrin activation and platelet aggregation
Moser, M., Nieswandt, B., Ussar, S., Pozgajova, M., & Fässler, R. (2008) · Nature Medicine · doi:10.1038/nm1722 · Cited by 700
Emerging Roles of Vascular Cell Adhesion Molecule-1 (VCAM-1) in Immunological Disorders and Cancer
Kong, D.-H., Kim, Y., Kim, M., Jang, J., & Lee, S. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19041057 · Cited by 683
Shrimali, R. K., Yu, Z., Theoret, M. R., Chinnasamy, D., Restifo, N. P., & Rosenberg, S. A. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0153 · Cited by 677
T-cell-antigen recognition and the immunological synapse
Huppa, J. B., & Davis, M. M. (2003) · Nature Reviews Immunology · doi:10.1038/nri1245 · Cited by 643
Coxon, A., Rieu, P., Barkalow, F. J., Askari, S., Sharpe, A. H., von Andrian, U. H., Arnaout, M. A., & Mayadas, T. N. (1996) · Immunity · doi:10.1016/s1074-7613(00)80278-2 · Cited by 627
Huehn, J., Siegmund, K., Lehmann, J. C. U., Siewert, C., Haubold, U., Feuerer, M., Debes, G. F., Lauber, J., Frey, O., Przybylski, G. K., et al. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031562 · Cited by 624
The integrin adhesome: from genes and proteins to human disease
Winograd-Katz, S. E., Fässler, R., Geiger, B., & Legate, K. R. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3769 · Cited by 623
The Role of Type 1 Conventional Dendritic Cells in Cancer Immunity
Böttcher, J. P., & Reis e Sousa, C. (2018) · Trends in Cancer · doi:10.1016/j.trecan.2018.09.001 · Cited by 607
Yu, J., Du, W., Yan, F., Wang, Y., Li, H., Cao, S., Yu, W., Shen, C., Liu, J., & Ren, X. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1201449 · Cited by 606
Röllig, C., Knop, S., & Bornhäuser, M. (2015) · The Lancet · doi:10.1016/s0140-6736(14)60493-1 · Cited by 603
Regulation of intercellular adhesion molecule-1 (CD54) gene expression
Roebuck, K. A., & Finnegan, A. (1999) · Journal of Leukocyte Biology · doi:10.1002/jlb.66.6.876 · Cited by 560
Targeting YAP-Dependent MDSC Infiltration Impairs Tumor Progression
Wang, G., Lu, X., Dey, P., Deng, P., Wu, C. C., Jiang, S., Fang, Z., Zhao, K., Konaparthi, R., Hua, S., et al. (2016) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-0224 · Cited by 553
Bell, D., Chomarat, P., Broyles, D., Netto, G., Harb, G. M., Lebecque, S., Valladeau, J., Davoust, J., Palucka, K. A., & Banchereau, J. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.10.1417 · Cited by 544
Integrin activation by talin, kindlin and mechanical forces
Sun, Z., Costell, M., & Fässler, R. (2019) · Nature Cell Biology · doi:10.1038/s41556-018-0234-9 · Cited by 543
The Structure and Assembly of Secreted Mucins
Perez-Vilar, J., & Hill, R. L. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.45.31751 · Cited by 531
Recent Advances in Targeting CD8 T-Cell Immunity for More Effective Cancer Immunotherapy
Durgeau, A., Virk, Y., Corgnac, S., & Mami-Chouaib, F. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00014 · Cited by 495
Arginase, Prostaglandins, and Myeloid-Derived Suppressor Cells in Renal Cell Carcinoma
Ochoa, A. C., Zea, A. H., Hernandez, C., & Rodriguez, P. C. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2197 · Cited by 489
Reardon, D. A., Fink, K. L., Mikkelsen, T., Cloughesy, T. F., O'Neill, A., Plotkin, S., Glantz, M., Ravin, P., Raizer, J. J., Rich, K. M., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.16.7510 · Cited by 481
The promise and potential pitfalls of chimeric antigen receptors
Sadelain, M., Brentjens, R., & Rivière, I. (2009) · Current Opinion in Immunology · doi:10.1016/j.coi.2009.02.009 · Cited by 467
Han, C., Jin, J., Xu, S., Liu, H., Li, N., & Cao, X. (2010) · Nature Immunology · doi:10.1038/ni.1908 · Cited by 455
β4 Integrin Amplifies ErbB2 Signaling to Promote Mammary Tumorigenesis
Guo, W., Pylayeva, Y., Pepe, A., Yoshioka, T., Muller, W. J., Inghirami, G., & Giancotti, F. G. (2006) · Cell · doi:10.1016/j.cell.2006.05.047 · Cited by 455
Nanoparticle-mediated drug delivery to tumor vasculature suppresses metastasis
Murphy, E. A., Majeti, B. K., Barnes, L. A., Makale, M., Weis, S. M., Lutu-Fuga, K., Wrasidlo, W., & Cheresh, D. A. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803728105 · Cited by 455
Expression of the integrin αEβ7identifies unique subsets of CD25+as well as CD25−regulatory T cells
Lehmann, J., Huehn, J., de la Rosa, M., Maszyna, F., Kretschmer, U., Krenn, V., Brunner, M., Scheffold, A., & Hamann, A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.192162899 · Cited by 454
Stupp, R., Hegi, M. E., Neyns, B., Goldbrunner, R., Schlegel, U., Clement, P. M. J., Grabenbauer, G. G., Ochsenbein, A. F., Simon, M., Dietrich, P.-Y., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.26.6650 · Cited by 454
Transforming Growth Factor-β and the Immune Response: Implications for Anticancer Therapy
Wrzesinski, S. H., Wan, Y. Y., & Flavell, R. A. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1157 · Cited by 452
Cayrol, R., Wosik, K., Berard, J. L., Dodelet-Devillers, A., Ifergan, I., Kebir, H., Haqqani, A. S., Kreymborg, K., Krug, S., Moumdjian, R., et al. (2008) · Nature Immunology · doi:10.1038/ni1551 · Cited by 444
Melero, I., Rouzaut, A., Motz, G. T., & Coukos, G. (2014) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-0985 · Cited by 435
TIGIT and CD 96: new checkpoint receptor targets for cancer immunotherapy
Dougall, W. C., Kurtulus, S., Smyth, M. J., & Anderson, A. C. (2017) · Immunological Reviews · doi:10.1111/imr.12518 · Cited by 435
The Molecular Basis of Filamin Binding to Integrins and Competition with Talin
Kiema, T., Lad, Y., Jiang, P., Oxley, C. L., Baldassarre, M., Wegener, K. L., Campbell, I. D., Ylänne, J., & Calderwood, D. A. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.01.011 · Cited by 434
HYPE or HOPE: the prognostic value of infiltrating immune cells in cancer
Barnes, T. A., & Amir, E. (2017) · British Journal of Cancer · doi:10.1038/bjc.2017.220 · Cited by 432
RIAM, an Ena/VASP and Profilin Ligand, Interacts with Rap1-GTP and Mediates Rap1-Induced Adhesion
Lafuente, E. M., van Puijenbroek, A. A. F. L., Krause, M., Carman, C. V., Freeman, G. J., Berezovskaya, A., Constantine, E., Springer, T. A., Gertler, F. B., & Boussiotis, V. A. (2004) · Developmental Cell · doi:10.1016/j.devcel.2004.07.021 · Cited by 420
Getting Leukocytes to the Site of Inflammation
Muller, W. A. (2013) · Veterinary Pathology · doi:10.1177/0300985812469883 · Cited by 400
Depleting tumor-specific Tregs at a single site eradicates disseminated tumors
Marabelle, A., Kohrt, H., Sagiv-Barfi, I., Ajami, B., Axtell, R. C., Zhou, G., Rajapaksa, R., Green, M. R., Torchia, J., Brody, J., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci64859 · Cited by 386
MAdCAM-1 has homology to immunoglobulin and mucin-like adhesion receptors and to IgA1
Briskin, M. J., McEvoy, L. M., & Butcher, E. C. (1993) · Nature · doi:10.1038/363461a0 · Cited by 377
McEver, R. P., & Zhu, C. (2010) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.042308.113238 · Cited by 376
Jang, J.-E., Hajdu, C. H., Liot, C., Miller, G., Dustin, M. L., & Bar-Sagi, D. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.06.062 · Cited by 372
Gutheil, J. C., Campbell, T. N., Pierce, P. R., Watkins, J. D., Huse, W. D., Bodkin, D., & Cheresh, D. A. (2000) · PubMed · Cited by 369
Kindlin-3 is required for β2 integrin–mediated leukocyte adhesion to endothelial cells
Moser, M., Bauer, M., Schmid, S., Ruppert, R., Schmidt, S., Sixt, M., Wang, H.-V., Sperandio, M., & Fässler, R. (2009) · Nature Medicine · doi:10.1038/nm.1921 · Cited by 367
T Regulatory Cells 1 Inhibit a Th2-Specific Response In Vivo
Cottrez, F., Hurst, S. D., Coffman, R. L., & Groux, H. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.9.4848 · Cited by 366
Johnson, J. P., Stade, B. G., Holzmann, B., Schwäble, W., & Riethmüller, G. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.2.641 · Cited by 359
Loss of E-Cadherin Promotes Ovarian Cancer Metastasis via α5-Integrin, which Is a Therapeutic Target
Sawada, K., Mitra, A. K., Radjabi, A. R., Bhaskar, V., Kistner, E. O., Tretiakova, M., Jagadeeswaran, S., Montag, A., Becker, A., Kenny, H. A., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5167 · Cited by 356
Taylor, P. A., Panoskaltsis-Mortari, A., Swedin, J. M., Lucas, P. J., Gress, R. E., Levine, B. L., June, C. H., Serody, J. S., & Blazar, B. R. (2004) · Blood · doi:10.1182/blood-2004-05-1850 · Cited by 351
Ahn, G.-O., Tseng, D., Liao, C.-H., Dorie, M. J., Czechowicz, A., & Brown, J. M. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0911378107 · Cited by 347
An inflammation-induced mechanism for leukocyte transmigration across lymphatic vessel endothelium
Johnson, L. A., Clasper, S., Holt, A. P., Lalor, P. F., Baban, D., & Jackson, D. G. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20051759 · Cited by 346
Lohr, J., Ratliff, T., Huppertz, A., Ge, Y., Dictus, C., Ahmadi, R., Grau, S., Hiraoka, N., Eckstein, V., Ecker, R. C., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2557 · Cited by 337
Aspord, C., Pedroza-Gonzalez, A., Gallegos, M., Tindle, S., Burton, E. C., Su, D., Marches, F., Banchereau, J., & Palucka, A. K. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20061120 · Cited by 334
Mlecnik, B., Tosolini, M., Charoentong, P., Kirilovsky, A., Bindea, G., Berger, A., Camus, M., Gillard, M., Bruneval, P., Fridman, W., et al. (2010) · Gastroenterology · doi:10.1053/j.gastro.2009.10.057 · Cited by 328
Dirkx, A. E. M., Egbrink, M. G. A. O., Kuijpers, M. J. E., van der Niet, S. T., Heijnen, V. V. T., Steege, J. C. A. B.-T., Wagstaff, J., & Griffioen, A. W. (2003) · PubMed · Cited by 325
Dendritic Cells Acquire Antigens from Live Cells for Cross-Presentation to CTL
Harshyne, L. A., Watkins, S. C., Gambotto, A., & Barratt-Boyes, S. M. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.6.3717 · Cited by 321
Vaillant, F., Asselin-Labat, M.-L., Shackleton, M., Forrest, N. C., Lindeman, G. J., & Visvader, J. E. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1949 · Cited by 314
v Integrins in Angiogenesis and Cancer
Weis, S. M., & Cheresh, D. A. (2011) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006478 · Cited by 311
Depleting tumor-specific Tregs at a single site eradicates disseminated tumors
Marabelle, A., Kohrt, H., Sagiv-Barfi, I., Ajami, B., Axtell, R. C., Zhou, G., Rajapaksa, R., Green, M. R., Torchia, J., Brody, J., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci73340 · Cited by 307
An integrin αvβ3–c-Src oncogenic unit promotes anchorage-independence and tumor progression
Desgrosellier, J. S., Barnes, L. A., Shields, D. J., Huang, M., Lau, S. K., Prévost, N., Tarin, D., Shattil, S. J., & Cheresh, D. A. (2009) · Nature Medicine · doi:10.1038/nm.2009 · Cited by 293
Phase I and Correlative Biology Study of Cilengitide in Patients With Recurrent Malignant Glioma
Nabors, L. B., Mikkelsen, T., Rosenfeld, S. S., Hochberg, F., Akella, N. S., Fisher, J. D., Cloud, G. A., Zhang, Y., Carson, K., Wittemer, S. M., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.6514 · Cited by 290
The molecular pathogenesis of chronic lymphocytic leukaemia
Fabbri, G., & Dalla-Favera, R. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.8 · Cited by 286
Burger, J. A., & Gribben, J. G. (2014) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2013.08.011 · Cited by 285
Griffioen, A. W., Damen, C. A., Martinotti, S., Blijham, G. H., & Groenewegen, G. (1996) · PubMed · Cited by 282
Theodosiou, M., Widmaier, M., Böttcher, R. T., Rognoni, E., Veelders, M., Bharadwaj, M., Lambacher, A., Austen, K., Müller, D. J., Zent, R., et al. (2016) · eLife · doi:10.7554/elife.10130 · Cited by 279
Signal transduction via integrin adhesion complexes
Humphries, J. D., Chastney, M. R., Askari, J. A., & Humphries, M. J. (2019) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2018.08.004 · Cited by 278
LFA-1-deficient mice show normal CTL responses to virus but fail to reject immunogenic tumor.
Schmits, R., Kündig, T. M., Baker, D. M., Shumaker, G., Simard, J. J., Duncan, G., Wakeham, A., Shahinian, A., van der Heiden, A., Bachmann, M. F., et al. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.4.1415 · Cited by 273
Tachibana, K., Nakanishi, H., Mandai, K., Ozaki, K., Ikeda, W., Yamamoto, Y., Nagafuchi, A., Tsukita, S., & Takai, Y. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.150.5.1161 · Cited by 272
Reprogramming the tumor microenvironment: tumor-induced immunosuppressive factors paralyze T cells
Wu, A. A., Drake, V., Huang, H.-S., Chiu, S., & Zheng, L. (2015) · OncoImmunology · doi:10.1080/2162402x.2015.1016700 · Cited by 271
Dirkx, A. E. M., Egbrink, M. G. A. O., Castermans, K., van der Schaft, D. W. J., Thijssen, V. L. J. L., Dings, R. P. M., Kwee, L., Mayo, K. H., Wagstaff, J., Steege, J. C. A. B., et al. (2006) · The FASEB Journal · doi:10.1096/fj.05-4493com · Cited by 270
Floc'h, A. L., Jalil, A., Vergnon, I., Chansac, B. L. M., Lazar, V., Bismuth, G., Chouaib, S., & Mami-Chouaib, F. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20061524 · Cited by 269
Klages, K., Mayer, C. T., Lahl, K., Loddenkemper, C., Teng, M. W. L., Ngiow, S. F., Smyth, M. J., Hamann, A., Huehn, J., & Sparwasser, T. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1736 · Cited by 267
Activation of Leukocyte β2 Integrins by Conversion from Bent to Extended Conformations
Nishida, N., Xie, C., Shimaoka, M., Cheng, Y., Walz, T., & Springer, T. A. (2006) · Immunity · doi:10.1016/j.immuni.2006.07.016 · Cited by 262
Verbovetski, I., Bychkov, H., Trahtemberg, U., Shapira, I., Hareuveni, M., Ben-Tal, O., Kutikov, I., Gill, O., & Mevorach, D. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020263 · Cited by 262
Weide, B., Martens, A., Zelba, H., Stutz, C., Derhovanessian, E., Di Giacomo, A. M., Maio, M., Sucker, A., Schilling, B., Schadendorf, D., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-2508 · Cited by 261
LFA-1 in T Cell Migration and Differentiation
Walling, B. L., & Kim, M. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00952 · Cited by 261
Efficiency of recombinant human TNF in human cancer therapy.
Lejeune, F. J., Líénard, D., Matter, M., & Rüegg, C. (2006) · PubMed · Cited by 256
Tumor masses support naive T cell infiltration, activation, and differentiation into effectors
Thompson, E. D., Enriquez, H. L., Fu, Y.-X., & Engelhard, V. H. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20092454 · Cited by 249
Gattei, V., Bulian, P., Del Principe, M. I., Zucchetto, A., Maurillo, L., Buccisano, F., Bomben, R., Dal-Bo, M., Luciano, F., Rossi, F. M., et al. (2008) · Blood · doi:10.1182/blood-2007-05-092486 · Cited by 248
Integrin-dependent phagocytosis – spreading from microadhesion to new concepts
Dupuy, A. G., & Caron, E. (2008) · Journal of Cell Science · doi:10.1242/jcs.018036 · Cited by 244
Clark, R. A., Huang, S. J., Murphy, G. F., Mollet, I. G., Hijnen, D., Muthukuru, M., Schanbacher, C. F., Edwards, V., Miller, D. M., Kim, J. E., et al. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20071190 · Cited by 243
Distinct roles for talin-1 and kindlin-3 in LFA-1 extension and affinity regulation
Lefort, C. T., Rossaint, J., Moser, M., Petrich, B. G., Zarbock, A., Monkley, S. J., Critchley, D. R., Ginsberg, M. H., Fässler, R., & Ley, K. (2012) · Blood · doi:10.1182/blood-2011-08-373118 · Cited by 242
Nabors, L. B., Fink, K. L., Mikkelsen, T., Grujicic, D., Tarnawski, R., Nam, D. H., Mazurkiewicz, M., Salacz, M., Ashby, L., Zagonel, V., et al. (2015) · Neuro-Oncology · doi:10.1093/neuonc/nou356 · Cited by 242
Integrins as Therapeutic Targets: Successes and Cancers
Raab-Westphal, S., Marshall, J., & Goodman, S. (2017) · Cancers · doi:10.3390/cancers9090110 · Cited by 241
Schlesinger, M., & Bendas, G. (2015) · International Journal of Cancer · doi:10.1002/ijc.28927 · Cited by 230
Akakura, S., Singh, S., Spataro, M., Akakura, R., Kim, J.-I., Albert, M. L., & Birge, R. B. (2004) · Experimental Cell Research · doi:10.1016/j.yexcr.2003.09.011 · Cited by 230
Fisher, D. T., Chen, Q., Skitzki, J. J., Muhitch, J. B., Zhou, L., Appenheimer, M. M., Vardam, T. D., Weis, E. L., Passanese, J., Wang, W.-C., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci44952 · Cited by 229
Selectins and glycosyltransferases in leukocyte rolling in vivo
Sperandio, M. (2006) · The FEBS Journal · doi:10.1111/j.1742-4658.2006.05437.x · Cited by 228
The integrin adhesome network at a glance
Horton, E. R., Humphries, J. D., James, J., Jones, M. C., Askari, J. A., & Humphries, M. J. (2016) · Journal of Cell Science · doi:10.1242/jcs.192054 · Cited by 224
Adjustment of dendritic cells to the breast-cancer microenvironment is subset specific
Michea, P., Noël, F., Zakine, E., Czerwinska, U., Sirven, P., Abouzid, O., Goudot, C., Scholer-Dahirel, A., Vincent-Salomon, A., Reyal, F., et al. (2018) · Nature Immunology · doi:10.1038/s41590-018-0145-8 · Cited by 223
β2 Integrins As Regulators of Dendritic Cell, Monocyte, and Macrophage Function
Schittenhelm, L., Hilkens, C. M., & Morrison, V. L. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01866 · Cited by 222
Regulation of integrin activity and signalling
Gahmberg, C. G., Fagerholm, S. C., Nurmi, S. M., Chavakis, T., Marchesan, S., & Grönholm, M. (2009) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2009.03.007 · Cited by 217
Self-citationCadherin-mediated cell–cell adhesion: sticking together as a family
Patel, S. D., Chen, C. P., Bahna, F., Honig, B., & Shapiro, L. (2003) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2003.10.007 · Cited by 215
Human tumor antigens recognized by T cells
Robbins, P. (1996) · Current Opinion in Immunology · doi:10.1016/s0952-7915(96)80078-1 · Cited by 210
Prostate cancer specific integrin αvβ3 modulates bone metastatic growth and tissue remodeling
McCabe, N. P., De, S., Vasanji, A., Brainard, J., & Byzova, T. V. (2007) · Oncogene · doi:10.1038/sj.onc.1210429 · Cited by 207
Circulating and tumor‐infiltrating myeloid cell subsets in patients with bladder cancer
Eruslanov, E., Neuberger, M., Daurkin, I., Perrin, G. Q., Algood, C., Dahm, P., Rosser, C., Vieweg, J., Gilbert, S. M., & Kusmartsev, S. (2012) · International Journal of Cancer · doi:10.1002/ijc.26123 · Cited by 205
Samanta, D., & Almo, S. C. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1763-4 · Cited by 205
Podgrabinska, S., Kamalu, O., Mayer, L., Shimaoka, M., Snoeck, H., Randolph, G. J., & Skobe, M. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0802167 · Cited by 204
Endothelial vascular cell adhesion molecule 1 expression is suppressed by melanoma and carcinoma.
Piali, L., Fichtel, A., Terpe, H. J., Imhof, B. A., & Gisler, R. H. (1995) · The Journal of experimental medicine · doi:10.1084/jem.181.2.811 · Cited by 201
The Role of Immunoglobulin Superfamily Cell Adhesion Molecules in Cancer Metastasis
Wai Wong, C., Dye, D. E., & Coombe, D. R. (2012) · International Journal of Cell Biology · doi:10.1155/2012/340296 · Cited by 200
The Tumor Vascular Endothelium as Decision Maker in Cancer Therapy
Klein, D. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00367 · Cited by 196
Teng, M. W. L., Ngiow, S. F., von Scheidt, B., McLaughlin, N., Sparwasser, T., & Smyth, M. J. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1681 · Cited by 192
Yoong, K. F., McNab, G., Hübscher, S. G., & Adams, D. H. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.8.3978 · Cited by 190
A Role for Class A Scavenger Receptor in Dendritic Cell Nibbling from Live Cells
Harshyne, L. A., Zimmer, M. I., Watkins, S. C., & Barratt-Boyes, S. M. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.5.2302 · Cited by 189
Hersey, P., Sosman, J., O'Day, S., Richards, J., Bedikian, A., Gonzalez, R., Sharfman, W., Weber, R., Logan, T., Buzoianu, M., et al. (2010) · Cancer · doi:10.1002/cncr.24821 · Cited by 189
Schnittert, J., Bansal, R., Storm, G., & Prakash, J. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.01.020 · Cited by 188
Cianfrocca, M. E., Kimmel, K. A., Gallo, J., Cardoso, T., Brown, M. M., Hudes, G., Lewis, N., Weiner, L., Lam, G. N., Brown, S. C., et al. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603171 · Cited by 184
The Role of Myeloid-Derived Suppressor Cells in Patients with Solid Tumors: A Meta-Analysis
Zhang, S., Ma, X., Zhu, C., Liu, L., Wang, G., & Yuan, X. (2016) · PLOS ONE · doi:10.1371/journal.pone.0164514 · Cited by 180
Bell-McGuinn, K. M., Matthews, C. M., Ho, S. N., Barve, M., Gilbert, L., Penson, R. T., Lengyel, E., Palaparthy, R., Gilder, K., Vassos, A., et al. (2011) · Gynecologic Oncology · doi:10.1016/j.ygyno.2010.12.362 · Cited by 179
Anikeeva, N., Somersalo, K., Sims, T. N., Thomas, V. K., Dustin, M. L., & Sykulev, Y. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502467102 · Cited by 179
CD11b facilitates the development of peripheral tolerance by suppressing Th17 differentiation
Ehirchiou, D., Xiong, Y., Xu, G., Chen, W., Shi, Y., & Zhang, L. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20062292 · Cited by 177
Integrin Cytoplasmic Tail Interactions
Morse, E. M., Brahme, N. N., & Calderwood, D. (2014) · Biochemistry · doi:10.1021/bi401596q · Cited by 175
Shulman, Z., Cohen, S. J., Roediger, B., Kalchenko, V., Jain, R., Grabovsky, V., Klein, E., Shinder, V., Stoler-Barak, L., Feigelson, S. W., et al. (2012) · Nature Immunology · doi:10.1038/ni.2173 · Cited by 174
Comrie, W. A., Li, S., Boyle, S., & Burkhardt, J. K. (2015) · Journal of Cell Biology · doi:10.1083/jcb.201406120 · Cited by 173
Microenvironment drug resistance in multiple myeloma: emerging new players
Di Marzo, L., Desantis, V., Solimando, A. G., Ruggieri, S., Annese, T., Nico, B., Fumarulo, R., Vacca, A., & Frassanito, M. A. (2016) · Oncotarget · doi:10.18632/oncotarget.10849 · Cited by 173
Serum levels of circulating intercellular adhesion molecule 1 in human malignant melanoma.
Harning, R., Mainolfi, E. A., Bystryn, J. C., et al. (1991) · PubMed · Cited by 172
Ways to Enhance Lymphocyte Trafficking into Tumors and Fitness of Tumor Infiltrating Lymphocytes
Bellone, M., & Calcinotto, A. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00231 · Cited by 167
Uhm, J. H., Dooley, N. P., Kyritsis, A. P., Rao, J., & Gladson, C. L. (1999) · PubMed · Cited by 165
Fagerholm, S. C., Guenther, C., Asens, M. L., Savinko, T., & Uotila, L. M. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00254 · Cited by 163
Self-citationRicart, A. D., Tolcher, A. W., Liu, G., Holen, K., Schwartz, G., Albertini, M., Weiss, G., Yazji, S., Ng, C., & Wilding, G. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0378 · Cited by 162
The leucocyte β2 (CD18) integrins: the structure, functional regulation and signalling properties
Tan, S.-M. (2012) · Bioscience Reports · doi:10.1042/bsr20110101 · Cited by 162
Shanafelt, T. D., Geyer, S. M., Bone, N. D., Tschumper, R. C., Witzig, T. E., Nowakowski, G. S., Zent, C. S., Call, T. G., LaPlant, B., Dewald, G. W., et al. (2008) · British Journal of Haematology · doi:10.1111/j.1365-2141.2007.06965.x · Cited by 161
Cell adhesion molecules and actin cytoskeleton at immune synapses and kinapses
Dustin, M. L. (2007) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2007.08.003 · Cited by 160
Control of CD8 T-Cell Infiltration into Tumors by Vasculature and Microenvironment
(2015) · Advances in Cancer Research · doi:10.1016/bs.acr.2015.05.001 · Cited by 159
Role of LFA-1 and ICAM-1 in Cancer
Reina, M., & Espel, E. (2017) · Cancers · doi:10.3390/cancers9110153 · Cited by 159
McNeel, D. G., Eickhoff, J. C., Lee, F. T., King, D. M., Alberti, D. B., Thomas, J. P., Friedl, A., Kolesar, J., Marnocha, R., Volkman, J., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0262 · Cited by 156
The Mechanism of Kindlin-Mediated Activation of Integrin αIIbβ3
Ye, F., Petrich, B. G., Anekal, P. V., Lefort, C. T., Kasirer‐Friede, A., Shattil, S. J., Ruppert, R., Moser, M., Fässler, R., & Ginsberg, M. H. (2013) · Current Biology · doi:10.1016/j.cub.2013.09.050 · Cited by 155
Interactions of tumor cells with dendritic cells: balancing immunity and tolerance
Dhodapkar, M. V., Dhodapkar, K. M., & Palucka, A. K. (2007) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4402247 · Cited by 154
ICAM-1 expression determines malignant potential of cancer
Roland, C. L., Harken, A. H., Sarr, M. G., & Barnett, C. C. (2007) · Surgery · doi:10.1016/j.surg.2007.01.016 · Cited by 150
Clinical Perspectives on Targeting of Myeloid Derived Suppressor Cells in the Treatment of Cancer
Najjar, Y. G., & Finke, J. H. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00049 · Cited by 149
Wang, L., Gordon, R. A., Huynh, L., Su, X., Min, K.-H. P., Han, J., Arthur, J. S. C., Kalliolias, G. D., & Ivashkiv, L. B. (2010) · Immunity · doi:10.1016/j.immuni.2010.03.014 · Cited by 146
Mullamitha, S., Ton, N. C., Parker, G. J. M., Jackson, A., Julyan, P. J., Roberts, C., Buonaccorsi, G. A., Watson, Y., Davies, K. E., Cheung, S., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2779 · Cited by 146
Molecular profiling to identify relevant immune resistance mechanisms in the tumor microenvironment
Gajewski, T. F., Fuertes, M. B., Spaapen, R. M., Zheng, Y., & Kline, J. P. (2010) · Current Opinion in Immunology · doi:10.1016/j.coi.2010.11.013 · Cited by 145
MacDonald, T. J., Stewart, C. F., Koçak, M., Goldman, S., Ellenbogen, R. G., Phillips∥, P. C., Lafond, D. A., Poussaint, T. Y., Kieran, M. W., Boyett, J. M., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.1812 · Cited by 144
Integrin extension enables ultrasensitive regulation by cytoskeletal force
Li, J., & Springer, T. A. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1704171114 · Cited by 144
Mittelbrunn, M., Molina, A., Escribese, M. M., Yáñez‐Mó, M., Escudero, E., Ursa, Á., Tejedor, R., Mampaso, F. M., & Sánchez‐Madrid, F. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307927101 · Cited by 143
Gilbert, M. R., Kuhn, J., Lamborn, K. R., Lieberman, F. S., Wen, P. Y., Mehta, M. P., Cloughesy, T. F., Lassman, A. B., DeAngelis, L. M., Chang, S. M., et al. (2011) · Journal of Neuro-Oncology · doi:10.1007/s11060-011-0650-1 · Cited by 140
Coupling Tumor Necrosis Factor-α with αV Integrin Ligands Improves Its Antineoplastic Activity
Curnis, F., Gasparri, A. M., Sacchi, A., Longhi, R., & Corti, A. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-1753 · Cited by 138
Lin, Y.-C., Shun, C., Wu, M., & Chen, C. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1393 · Cited by 134
Takayama, S., Ishii, S., Ikeda, T., Masamura, S., Doi, M., & Kitajima, M. (2005) · PubMed · Cited by 134
Frieß, H., Langrehr, J. M., Oettle, H., Raedle, J., Niedergethmann, M., Dittrich, C., HOSSFELD, D. K., Stöger, H., Neyns, B., Herzog, P., et al. (2006) · BMC Cancer · doi:10.1186/1471-2407-6-285 · Cited by 133
Rogers, P., & Croft, M. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.6.2955 · Cited by 132
Kappelmayer, J., & Nagy, B. (2017) · BioMed Research International · doi:10.1155/2017/6138145 · Cited by 132
Élez, E., Kocáková, I., Höhler, T., Martens, U. M., Bokemeyer, C., Cutsem, E. V., Melichar, B., Šmakal, M., Csőszi, T., Топузов, Э. Э., et al. (2014) · Annals of Oncology · doi:10.1093/annonc/mdu474 · Cited by 131
Vacca, A., Loreto, M. D., Ribatti, D., Stefano, R. D., Gadaleta‐Caldarola, G., Iodice, G., Caloro, D., & Dammacco, F. (1995) · American Journal of Hematology · doi:10.1002/ajh.2830500103 · Cited by 131
Garbi, N., Arnold, B., Gordon, S., Hämmerling, G. J., & Ganß, R. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.10.5861 · Cited by 128
The Role of Vascular Cell Adhesion Molecule-1 in Tumor Immune Evasion
Wu, T. ‐. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1543 · Cited by 128
Importance of integrin LFA-1 deactivation for the generation of immune responses
Semmrich, M., Smith, A. M., Feterowski, C., Beer, S., Engelhardt, B., Busch, D. H., Bartsch, B., Laschinger, M., Hogg, N., Pfeffer, K., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041850 · Cited by 128
Guillerey, C., Nakamura, K., Vučković, S., Hill, G. R., & Smyth, M. J. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2135-z · Cited by 128
Integrin α4β1 Promotes Monocyte Trafficking and Angiogenesis in Tumors
Jin, H., Su, J., Garmy-Susini, B., Kleeman, J., & Varner, J. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2704 · Cited by 127
Borchers, A. T., Shimoda, S., Bowlus, C. L., Keen, C. L., & Gershwin, M. E. (2009) · Seminars in Immunopathology · doi:10.1007/s00281-009-0167-2 · Cited by 125
CD103 is a hallmark of tumor‐infiltrating regulatory T cells
Anz, D., Mueller, W., Golić, M., Kunz, W. G., Rapp, M., Koelzer, V. H., Ellermeier, J., Ellwart, J. W., Schnurr, M. M., Bourquin, C., et al. (2011) · International Journal of Cancer · doi:10.1002/ijc.25902 · Cited by 122
Perspectives on Chimeric Antigen Receptor T-Cell Immunotherapy for Solid Tumors
Kosti, P., Maher, J. F., & Arnold, J. N. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01104 · Cited by 122
on the behalf of the CNTO 95 Investigators, O'Day, S. J., Pavlick, A. C., Loquai, C., Lawson, D. H., Gutzmer, R., Richards, J. M., Schadendorf, D., Thompson, J. A., Gonzalez, R. C., et al. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.183 · Cited by 120
Škoberne, M., Somersan, S., Almodovar, W., Truong, T., Petrova, K., Henson, P. M., & Bhardwaj, N. (2006) · Blood · doi:10.1182/blood-2005-12-4812 · Cited by 112
Cited by
CD8+ T cell differentiation and dysfunction in cancer
Philip, M., & Schietinger, A. (2022) · Nature Reviews Immunology · doi:10.1038/s41577-021-00574-3 · Cited by 1,052
TGFβ biology in cancer progression and immunotherapy
Derynck, R., Turley, S. J., & Akhurst, R. J. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-0403-1 · Cited by 944
Bui, T. M., Wiesolek, H. L., & Sumagin, R. (2020) · Journal of Leukocyte Biology · doi:10.1002/jlb.2mr0220-549r · Cited by 957
Advancing therapy for osteosarcoma
Gill, J., & Gorlick, R. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-021-00519-8 · Cited by 876
Cell adhesion in cancer: Beyond the migration of single cells
Janiszewska, M., Primi, M. C., & Izard, T. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.rev119.007759 · Cited by 646
Metadata
- Authors
- Harjunpää, H., Llort Asens, M., Guenther, C., & Fagerholm, S. C.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2019-05-22
- Volume
- 10
- Pages
- 1078-1078
- ISSN
- 1664-3224 (ISSN-L)
- OpenAlex
- W2945537500
- Cited by
- 764
- References
- 297
- FWCI
- 49.88
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.